Biosynex
Designs and distributes medical diagnostic solutions, including rapid tests and devices.
ALBIO | PA
Overview
Corporate Details
- ISIN(s):
- FR0011005933
- LEI:
- 969500H4BGE1HBLGP566
- Country:
- France
- Address:
- 22 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN
- Website:
- https://www.biosynex.com/en/
- Sector:
- Manufacturing
Description
Biosynex is a company that specializes in the design, manufacture, and distribution of medical diagnostic solutions. Its core product line consists of Rapid Diagnostic Tests (RDTs) for both professional use in clinical settings and for self-testing by the general public. The professional portfolio includes point-of-care (POC) instruments, molecular biology diagnostics (such as PCR tests), and a wide array of immunodiagnostic assays. For the consumer market, Biosynex offers various self-tests and a range of prevention and monitoring devices, including thermometers, blood pressure monitors, and pulse oximeters. The company focuses on providing simple, rapid, and effective tools for screening, diagnosis, and prevention.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-02 08:00 |
BIOSYNEX SA: ProciseDx obtient les premières autorisations de la FDA pour des t…
|
French | 357.0 KB | ||
| 2023-09-29 18:05 |
BIOSYNEX SA: PROJET DE FUSION PAR ABSORPTION DE THERADIAG PAR BIOSYNEX
|
French | 329.0 KB | ||
| 2023-09-29 18:00 |
BIOSYNEX SA: RÉSULTATS SEMESTRIELS 2023 IMPACTÉS PAR LA FIN DE LA PANDÉMIE ET …
|
French | 368.0 KB | ||
| 2023-09-01 18:00 |
BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 31 AOÛT …
|
French | 122.6 KB | ||
| 2023-08-01 18:00 |
BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 31 JUILLE…
|
French | 121.1 KB | ||
| 2023-07-21 08:00 |
BIOSYNEX SA: ACQUISITION DE LA TOTALITE DU CAPITAL DE LA SOCIETE QUALIGEN INC. …
|
French | 696.1 KB | ||
| 2023-07-20 18:00 |
BIOSYNEX SA: CHIFFRE D’AFFAIRES DU 1er SEMESTRE 2023 : 42,8 M€
|
French | 631.7 KB | ||
| 2023-07-04 08:30 |
BIOSYNEX SA: DÉCLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 30 JUIN 2…
|
French | 289.9 KB | ||
| 2023-06-12 08:30 |
BIOSYNEX SA: PRISE DE CONTROLE ET ACQUISITION DE LA TOTALITE DU CAPITAL DE LA …
|
French | 334.6 KB | ||
| 2023-06-08 18:00 |
BIOSYNEX SA: BIOSYNEX ANNONCE L’ACQUISITION DE L’ACTIVITE « SOINS OCULAIRES » …
|
French | 387.9 KB | ||
| 2023-06-02 18:00 |
BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 31 MAI 20…
|
French | 122.0 KB | ||
| 2023-05-05 18:02 |
BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 30 AVRI…
|
French | 124.5 KB | ||
| 2023-04-27 23:30 |
BIOSYNEX SA: REALISATION DE L’ACQUISITION DE CHEMBIO DIAGNOSTICS, INC.
|
French | 680.1 KB | ||
| 2023-04-20 18:00 |
BIOSYNEX SA: RESULTATS ANNUELS 2022 - POURSUITE DU PLAN DE TRANSFORMATION EN 20…
|
French | 373.2 KB | ||
| 2023-04-13 18:00 |
BIOSYNEX SA: PROLONGATION DE LA PERIODE D’OFFRE PUBLIQUE D’ACHAT SUR LES TITRES…
|
French | 272.8 KB |
Automate Your Workflow. Get a real-time feed of all Biosynex filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biosynex
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biosynex via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
